Clinical Trials Directory

Trials / Unknown

UnknownNCT04918875

Oxygen Requirements and Use in Patients With COVID-19 in LMICs

Oxygen Requirements and Approaches to Respiratory Support in Patients With COVID-19 in LMICs: A WHO Study

Status
Unknown
Phase
Study type
Observational
Enrollment
2,400 (estimated)
Sponsor
Pryanka Relan · Academic / Other
Sex
All
Age
12 Years
Healthy volunteers
Not accepted

Summary

This observational cohort study will enroll patients in LMICs with suspected or confirmed COVID-19 on oxygen or deemed to require oxygen therapy based on objective criteria. Demographics and risk factor information will be collected from participants. Participants will be followed for 7 days or until outcome (hospital discharge or death). Facility level metrics on oxygen availability will also be collected at the beginning of site enrolment.

Detailed description

The COVID-19 pandemic has highlighted, more than ever, the acute need for scale up of oxygen therapy. WHO has provided an inventory tool to quantify facility-level provision of infrastructure to deliver oxygen therapy. However, data on the use of oxygen therapy at the patient-level remains lacking. This observational cohort study will enroll patients in LMICs with suspected or confirmed COVID-19 on oxygen or deemed to require oxygen therapy based on objective criteria. Demographics and risk factor information will be collected from participants. Participants will be followed for 7 days or until outcome (hospital discharge or death). Facility level metrics on oxygen availability will also be collected at the beginning of site enrolment.

Conditions

Timeline

Start date
2022-01-01
Primary completion
2023-04-30
Completion
2023-10-30
First posted
2021-06-09
Last updated
2023-08-23

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04918875. Inclusion in this directory is not an endorsement.